Floatz logo

Orca-Q

Acute Lymphoblastic Leukemia

University of FloridaCell therapyPhase 1/2Active
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
65/ 100

Competitive context

182 Active assets in the Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
THIOGUANINE ANHYDROUS
St. Jude Children's Research Hospital
Phase 4BBB
ASPARAGINASE
Centre Hospitalier Universitaire de Nice
Phase 4BB
Daunorubicin
PETHEMA Foundation
Phase 4BB
PEGASPARGASE
Dana-Farber Cancer Institute
Phase 4BB
MERCAPTOPURINE ANHYDROUS
Dana-Farber Cancer Institute
Phase 4BB

View all 50 →

Same molecule, other indications

Orca-Q is also rated in:

acute lymphoblastic leukemiaDormant
CCC
Indicative ·
48 / 100
View asset →
blast phase chronic myelogenous leukemia, BCR-ABL1 positiveDormant
CCC
Indicative ·
48 / 100
View asset →
mixed phenotype acute leukemiaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →